V. Oliynyk, O. Epshtein, T. Sovenko, et al.
11. Dean D.S., Hay I.D.
effect of radioiodine. Other factors to be considered
may be represented by as yet unknown peculiarities
of post-Chernobyl thyroid carcinomas, although tech-
nical aspects, such as less radical surgical procedures
cannot be ruled out.
Prognostic indicators in differentiated thyroid carci-
noma.
Cancer Control 2000, 7: 229-239.
12. Mazzaferri E.L.
Long-term outcome of patients with differentiated
thyroid carcinoma: effect of therapy.
Endocr. Pract. 2000, 6: 469-476.
ACNOWLEDGMENTS
This study has been supported in part by grant from European
Communities: INCO-Copernicus Project (IC15-CT980314);
MURST (ex 40%) 2000.
13. Nikiforov Y., Gnepp D.R.
Pediatric thyroid cancer after the Chernobyl disaster.
Pathomorphologic study of 84 cases (1991-1992)
from the republic of Belarus.
Cancer 1994, 74: 748-766.
REFERENCES
14. Williams E.D., Pacini F., Pinchera A.
Thyroid cancer following Chernobyl.
J. Endocrinol. Invest. 1995, 18: 144-146.
1. Dulgeroff A.J., Hershman J.M.
Medical therapy for differentiated thyroid carcinoma.
Endocr. Rev. 1994, 15: 500-515.
15. Pacini F., Vorontsova T., Demidchik E.P., Molinaro
E., Agate L., Romei C., Shavrova E., Cherstvoy E.D.,
Ivashkevitch Y., Kuchinskaya E., Schlumberger M.,
Ronga G., Filesi M., Pinchera A.
2. Solomon D.L., Wartofsky L., Burman K.D.
Current trends in the management of well differen-
tiated papillary thyroid carcinoma.
J. Clin. Endocrinol. Metab. 1966, 81: 333-339.
3. Schlumberger M.
Post-Chernobyl thyroid carcinoma in Belarus chil-
dren and adolescents: comparison with naturally oc-
curring thyroid carcinoma in Italy and France.
J. Clin. Endocrinol. Metab. 1997, 82: 3563-3569.
Papillary and follicular thyroid carcinoma.
N. Engl. J. Med. 1998, 338: 297-306.
4. De Groot L.J., Reilly M.
16. Schlumberger M., Arcangioli O., Piekarski J.D.,
Tubiana M., Parmentier C.
Comparison of 30-and 50-mCi doses of iodine-131
for thyroid ablation.
Detection and treatment of lung metastases of dif-
ferentiated thyroid carcinoma in patients with nor-
mal chest x-ray.
Ann. Inter. Med. 1982, 96: 51-53.
5. Goolden A.W.G.
J. Nucl. Med. 1988, 29: 1790-1794.
The use of radioactive iodine in thyroid carcinoma.
Eur. J. Cancer Clin. Onc. 1988, 24: 339-343.
17. Tronko M., Bogdanova T., Komissarenko I.V.,
Epstein O.V., Oliynyk V., Kovalenko A., Likhtarev
I.A., Kairo I., Peters S.B., LiVolsi V.A.
6. Wartofsky L., Sherman S.I., Gopal J., Schlumberger
M., Hay I.D.
Thyroid carcinoma in children and adolescents in
Ukraine after the Chernobyl nuclear accident.
Cancer 1999, 86: 149-156.
Therapeutic controversy. The use of radioactive iodine
in patients with papillary and follicular thyroid cancer.
J. Clin. Endocrinol. Metab. 1998, 83: 4195-4203
18. Maxon III H.R., Smith H.S.
7. Grebe S.K.G., Hay I.D.
Radioiodine-131 in the diagnosis and treatment of
metastatic well differentiated thyroid cancer.
Endocrinol. Metab. Clin. North Am. 1990, 19: 685-
718.
Follicular cell-derived thyroid carcinoma.
In: Arnold A. (Ed.), Endocrine neoplasms.
Kluwer Academic Publishers, Boston, 1997, p. 91.
8. Pacini F., Lari R., Mazzeo S., Grasso L., Taddei D.,
Pinchera A.
19. Samuel A.M., Rajashekharrao B.
Radioiodine therapy for well-differentiated thyroid
cancer: a quantitative dosimetric evaluation for rem-
nant thyroid ablation after surgery.
Diagnostic value of a single serum thyroglobulin de-
termination on and off thyroid suppressive therapy
in the follow-up of patients with differentiated thy-
roid cancer.
J. Nucl. Med. 1994, 35: 1944-1950.
Clin. Endocrinol. (Oxf). 1985, 23: 405-411.
20. De Klerk J.M.H., De Keizer B., Zelissen P.M.J., Lips
C.M.J., Koppeschaar H.P.F.
9. Pacini F., Elisei R., Fugazzola L., Cetani F, Romei C,
Mancusi F, Pinchera A.
Fixed dosage of 131-I for remnant ablation in pa-
tients with differentiated thyroid carcinoma without
pre-ablative diagnostic 131-I scintigraphy.
Nucl. Med. Commun. 2000, 21: 529-532.
Post-surgical follow-up of differentiated thyroid
cancer.
J. Endocrinol. Invest. 1995, 18: 165-166.
10. Schlumberger M., Baudin E.
21. Doi S.A.R., Woodhouse N.J.Y.
Serum thyroglobulin determination in the follow up
of patients with differentiated thyroid carcinoma.
Eur. J. Endocrinol. 1998, 138: 249-252.
Ablation of the thyroid remnant and 131-I dose in
differentiated thyroid cancer.
Clin. Endocrinol. (Oxf.) 2000, 52: 765-773.
447